New Medical Literature Examines Rare Neurological Illness, GBS, and Link to Vaccination

 Posted on October 29, 2026 in Vaccine Information

Blog ImageEarlier this year, a paper written by authors from various major institutions discussed the potential risk of a rare neurological illness, Guillain-Barre syndrome ("GBS"), following vaccination 

GBS is a neurological syndrome that involves damage to nerve cells leading to weakness and even paralysis. The syndrome can vary in intensity, with some people experiencing minor symptoms while others suffer from extended courses that require significant medical intervention, including hospital stays and long stays in rehabilitation facilities. Since the 1970’s, it has been acknowledged that in rare instances, seasonal flu vaccination can trigger GBS. In the Vaccine Injury Compensation Program, that connection has been explicitly acknowledged. Additionally, other vaccines have also been found to have triggered GBS in some circumstances.

In the recent article examining GBS and vaccination, the authors confirmed the previously identified connection between GBS following flu vaccination. They also identified statistical signals for potential associations of GBS and vaccines against pneumococcal, Tdap or tetanus containing vaccines, zoster vaccines and a particular Covid-19 vaccine product. The risk period occurred between 1-42 days following vaccination.

It’s important to note that the risk of developing GBS following vaccination remains rare, but this article does support the view that in some individuals, a recent vaccination can be the trigger for illness.

In our firm, we have worked on behalf of people injured by GBS following flu vaccinations, Prevnar vaccinations, Tdap or tetanus containing vaccines, HPV vaccinations and Hepatitis A/B vaccinations.  While every case is different, our experience in handling cases involving GBS and understanding the complex medical, occupational and emotional challenges involved in serious illness, has helped us to successfully advocate for our clients over the last two decades.

You can learn more about our firm and our work here.

The article discussed above, lead author Yih, is also readily accessible and can be viewed online.

Share this post:
Back to Top